A magnetic switch for the control of cell death signalling in in vitro and in vivo systems.

The regulation of cellular activities in a controlled manner is one of the most challenging issues in fields ranging from cell biology to biomedicine. Nanoparticles have the potential of becoming useful tools for controlling cell signalling pathways in a space and time selective fashion. Here, we have developed magnetic nanoparticles that turn on apoptosis cell signalling by using a magnetic field in a remote and non-invasive manner. The magnetic switch consists of zinc-doped iron oxide magnetic nanoparticles (Zn(0.4)Fe(2.6)O(4)), conjugated with a targeting antibody for death receptor 4 (DR4) of DLD-1 colon cancer cells. The magnetic switch, in its On mode when a magnetic field is applied to aggregate magnetic nanoparticle-bound DR4s, promotes apoptosis signalling pathways. We have also demonstrated that the magnetic switch is operable at the micrometre scale and that it can be applied in an in vivo system where apoptotic morphological changes of zebrafish are successfully induced.

[1]  H. Matsuda.  The Current Trends and Future Prospects of Regenerative Medicine in Cardiovascular Diseases , 2005, Asian cardiovascular & thoracic annals.

[2]  Gwyn T. Williams.  Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[3]  S. de Jong,et al.  TRAIL receptor signalling and modulation: Are we on the right TRAIL? , 2009, Cancer treatment reviews.

[4]  A. Look,et al.  Zebrafish as a powerful vertebrate model system for in vivo studies of cell death. , 2007, Seminars in cancer biology.

[5]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[6]  Donald E Ingber,et al.  Nanomagnetic actuation of receptor-mediated signal transduction. , 2008, Nature nanotechnology.

[7]  R. Herbst,et al.  To kill a tumor cell: the potential of proapoptotic receptor agonists. , 2008, The Journal of clinical investigation.

[8]  M. Yamashita.  Apoptosis in zebrafish development. , 2003, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[9]  J. Hörber,et al.  Sphingolipid–Cholesterol Rafts Diffuse as Small Entities in the Plasma Membrane of Mammalian Cells , 2000, The Journal of cell biology.

[10]  Luke P. Lee,et al.  Remote optical switch for localized and selective control of gene interference. , 2009, Nano letters.

[11]  J. Cheon,et al.  Artificial control of cell signaling and growth by magnetic nanoparticles. , 2010, Angewandte Chemie.

[12]  Jinwoo Cheon,et al.  Critical enhancements of MRI contrast and hyperthermic effects by dopant-controlled magnetic nanoparticles. , 2009, Angewandte Chemie.

[13]  Brenton D. Hoffman,et al.  Dynamic molecular processes mediate cellular mechanotransduction , 2011, Nature.

[14]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[15]  Ehud Y. Isacoff,et al.  Optical Switches for Remote and Noninvasive Control of Cell Signaling , 2008, Science.

[16]  J. Dobson,et al.  Magnetic micro- and nanoparticle mediated activation of mechanosensitive ion channels. , 2005, Medical engineering & physics.

[17]  A. Ashkenazi,et al.  Delineation of the cell-extrinsic apoptosis pathway in the zebrafish , 2006, Cell Death and Differentiation.

[18]  Heng Huang,et al.  Remote control of ion channels and neurons through magnetic-field heating of nanoparticles. , 2010, Nature nanotechnology.

[19]  T. Sayers.  Targeting the extrinsic apoptosis signaling pathway for cancer therapy , 2011, Cancer Immunology, Immunotherapy.

[20]  Thierry Gacoin,et al.  Observing the confinement potential of bacterial pore-forming toxin receptors inside rafts with nonblinking Eu(3+)-doped oxide nanoparticles. , 2012, Biophysical journal.

[21]  D. Meeker,et al.  Finite Element Method Magnetics , 2002 .

[22]  D. Kabelitz,et al.  Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. , 2004, Immunity.

[23]  Jon Dobson,et al.  Remote control of cellular behaviour with magnetic nanoparticles. , 2008, Nature nanotechnology.

[24]  Alicia J El Haj,et al.  Controlled differentiation of human bone marrow stromal cells using magnetic nanoparticle technology. , 2010, Tissue engineering. Part A.

[25]  D. Green,et al.  Apoptosis and oncogenesis: give and take in the BCL-2 family. , 2011, Current opinion in genetics & development.

[26]  J. Szöllősi,et al.  Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. , 2011, Carcinogenesis.

[27]  A. Ashkenazi,et al.  Targeting death and decoy receptors of the tumour-necrosis factor superfamily , 2002, Nature Reviews Cancer.

[28]  J. Bobe,et al.  Molecular cloning and expression of a TNF receptor and two TNF ligands in the fish ovary. , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[29]  R. Jerala,et al.  Toll-Like Receptor 4 Activation in Cancer Progression and Therapy , 2011, Clinical & developmental immunology.

[30]  S. Fulda,et al.  Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy , 2006, Oncogene.

[31]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[32]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[33]  D. Ingber,et al.  Mechanotransduction across the cell surface and through the cytoskeleton , 1993 .

[34]  R. Iyengar,et al.  Signaling Networks The Origins of Cellular Multitasking , 2000, Cell.

[35]  A. Ashkenazi,et al.  The zebrafish as a model organism for the study of apoptosis , 2010, Apoptosis.

[36]  Carlos Rinaldi,et al.  EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. , 2011, ACS nano.

[37]  Тетяна Миколаївна Плохута,et al.  Application of magnetic nanoparticles in biomedicine , 2011 .

[38]  Derek Toomre,et al.  Spatial control of EGF receptor activation by reversible dimerization on living cells , 2010, Nature.

[39]  A. Ashkenazi,et al.  Targeting death receptors in cancer with Apo2L/TRAIL. , 2004, Current opinion in pharmacology.

[40]  S. Storey.  Targeting apoptosis: selected anticancer strategies , 2008, Nature Reviews Drug Discovery.